Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Humphrey

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials GroupM J Moore, J Hamm, J Dancey, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2003
Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis mediaWilliam R Humphrey, Mark H Shattuck, Raymond J Zielinski, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
Lovastatin-Induced Phosphatidylinositol-4-Phosphate 5-Kinase Diffusion from Microvilli Stimulates ROMK ChannelsBing-Chen Liu, Li-Li Yang, Xiao-Yu Lu, et al.
Veterinary Dermatology|January 22, 2013
Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitisAndrea J Gonzales, William R Humphrey, James E Messamore, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumorsE I Heath, S O'Reilly, R Humphrey, et al.
AIDS (London, England)|November 5, 1999
HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patientsL A Pinto, J A Berzofsky, K R Fowke, et al.
Molecular Genetics and Metabolism|February 13, 2017
UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatmentJ Vockley, B Burton, G T Berry, et al.
Journal of Medicinal Chemistry|August 1, 1979
Synthesis and biological activity of peptide antagonists of luliberin (luteinizing hormone-releasing hormone)G W Moersch, M C Rebstock, E L Wittle, et al.
The Journal of Allergy and Clinical Immunology. Global|May 27, 2026
Irradiation does not impact the immunogenicity of food flours used for oral immunotherapyTimothy P Moran, Anusha Penumarti, Robert M Immormino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2010
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II studyS J O'Day, M Maio, V Chiarion-Sileni, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials GroupM J Moore, J Hamm, J Dancey, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2003
Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis mediaWilliam R Humphrey, Mark H Shattuck, Raymond J Zielinski, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
Lovastatin-Induced Phosphatidylinositol-4-Phosphate 5-Kinase Diffusion from Microvilli Stimulates ROMK ChannelsBing-Chen Liu, Li-Li Yang, Xiao-Yu Lu, et al.
Veterinary Dermatology|January 22, 2013
Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitisAndrea J Gonzales, William R Humphrey, James E Messamore, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumorsE I Heath, S O'Reilly, R Humphrey, et al.
AIDS (London, England)|November 5, 1999
HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patientsL A Pinto, J A Berzofsky, K R Fowke, et al.
Molecular Genetics and Metabolism|February 13, 2017
UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatmentJ Vockley, B Burton, G T Berry, et al.
Journal of Medicinal Chemistry|August 1, 1979
Synthesis and biological activity of peptide antagonists of luliberin (luteinizing hormone-releasing hormone)G W Moersch, M C Rebstock, E L Wittle, et al.
The Journal of Allergy and Clinical Immunology. Global|May 27, 2026
Irradiation does not impact the immunogenicity of food flours used for oral immunotherapyTimothy P Moran, Anusha Penumarti, Robert M Immormino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2010
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II studyS J O'Day, M Maio, V Chiarion-Sileni, et al.
Pageof 15